These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 27279251)

  • 1. β-Blockers and Vascular Hemodynamics in Patients With Peripheral Arterial Disease.
    Schlager O; Gajdosova Kovacicova L; Senn O; Amann-Vesti B; Wilkinson IB; Jacomella V; Husmann M
    J Clin Hypertens (Greenwich); 2016 Dec; 18(12):1244-1249. PubMed ID: 27279251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different associations between beta-blockers and other antihypertensive medication combinations with brachial blood pressure and aortic waveform parameters.
    Sluyter JD; Hughes AD; Lowe A; Parker KH; Camargo CA; Hametner B; Wassertheurer S; Scragg RK
    Int J Cardiol; 2016 Sep; 219():257-63. PubMed ID: 27340919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of renin-angiotensin-aldosterone system inhibitors and beta-blockers on markers of arterial stiffness.
    Koumaras C; Tziomalos K; Stavrinou E; Katsiki N; Athyros VG; Mikhailidis DP; Karagiannis A
    J Am Soc Hypertens; 2014 Feb; 8(2):74-82. PubMed ID: 24139833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aortic augmentation index is independently associated with N-terminal pro B-type natriuretic peptide in patients with peripheral arterial disease.
    Shahin Y; Chetter I
    Vasc Endovascular Surg; 2012 Nov; 46(8):648-53. PubMed ID: 23047817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between arterial stiffness and peripheral artery disease as measured by radial artery tonometry.
    Zahner GJ; Gruendl MA; Spaulding KA; Schaller MS; Hills NK; Gasper WJ; Grenon SM
    J Vasc Surg; 2017 Nov; 66(5):1518-1526. PubMed ID: 28756044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severity of peripheral arterial disease is associated with aortic pressure augmentation and subendocardial viability ratio.
    Mosimann K; Jacomella V; Thalhammer C; Meier TO; Kohler M; Amann-Vesti B; Husmann M
    J Clin Hypertens (Greenwich); 2012 Dec; 14(12):855-60. PubMed ID: 23205752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aortic augmentation index in patients with peripheral arterial disease.
    Catalano M; Scandale G; Carzaniga G; Cinquini M; Minola M; Antoniazzi V; Dimitrov G; Carotta M
    J Clin Hypertens (Greenwich); 2014 Nov; 16(11):782-7. PubMed ID: 25228305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Central blood pressure as an index of antihypertensive control: determinants and potential value.
    Trudeau L
    Can J Cardiol; 2014 May; 30(5 Suppl):S23-8. PubMed ID: 24750979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of CPAP on "vascular" risk factors in patients with obstructive sleep apnea and arterial hypertension.
    Litvin AY; Sukmarova ZN; Elfimova EM; Aksenova AV; Galitsin PV; Rogoza AN; Chazova IE
    Vasc Health Risk Manag; 2013; 9():229-35. PubMed ID: 23690688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different patterns of peripheral versus central blood pressure in hypertensive patients treated with β-blockers either with or without vasodilator properties or with angiotensin receptor blockers.
    Polónia J; Barbosa L; Silva JA; Bertoquini S
    Blood Press Monit; 2010 Oct; 15(5):235-9. PubMed ID: 20577082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Total vascular resistance, augmentation index, and augmentation pressure increase in patients with peripheral artery disease.
    Takemoto R; Uchida HA; Toda H; Okada K; Otsuka F; Ito H; Wada J
    Medicine (Baltimore); 2021 Aug; 100(32):e26931. PubMed ID: 34397939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arterial stiffness and peripheral arterial disease in patients with systemic lupus erythematosus.
    Tziomalos K; Gkougkourelas I; Sarantopoulos A; Bekiari E; Makri E; Raptis N; Tselios K; Pantoura M; Hatzitolios AI; Boura P
    Rheumatol Int; 2017 Feb; 37(2):293-298. PubMed ID: 27873008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discordant effects of beta-blockade on central aortic systolic and brachial systolic blood pressure: considerations beyond the cuff.
    Epstein BJ; Anderson S
    Pharmacotherapy; 2007 Sep; 27(9):1322-33. PubMed ID: 17723086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arterial stiffness and subendocardial viability ratio in patients with peripheral arterial disease.
    Scandale G; Dimitrov G; Recchia M; Carzaniga G; Minola M; Perilli E; Carotta M; Catalano M
    J Clin Hypertens (Greenwich); 2018 Mar; 20(3):478-484. PubMed ID: 29447429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative effectiveness of a fixed-dose combination of losartan + HCTZ versus bisoprolol + HCTZ in patients with moderate-to-severe hypertension: results of the 6-month ELIZA trial.
    Radchenko GD; Sirenko YM; Kushnir SM; Torbas OO; Dobrokhod AS
    Vasc Health Risk Manag; 2013; 9():535-49. PubMed ID: 24109189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A meta-analysis of randomized controlled trials assessing the impact of beta-blockers on arterial stiffness, peripheral blood pressure and heart rate.
    Niu W; Qi Y
    Int J Cardiol; 2016 Sep; 218():109-117. PubMed ID: 27232921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of low-dose atorvastatin on arterial stiffness and central aortic pressure augmentation in patients with hypertension and hypercholesterolemia.
    Kanaki AI; Sarafidis PA; Georgianos PI; Kanavos K; Tziolas IM; Zebekakis PE; Lasaridis AN
    Am J Hypertens; 2013 May; 26(5):608-16. PubMed ID: 23449607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of aliskiren on arterial stiffness and endothelial function in patients with primary hypertension.
    Bonadei I; Vizzardi E; D'Aloia A; Sciatti E; Raddino R; Metra M
    J Clin Hypertens (Greenwich); 2014 Mar; 16(3):202-6. PubMed ID: 24708382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haemodynamic Influences of Bisoprolol in Hypertensive Middle-Aged Men: A Double-Blind, Randomized, Placebo-Controlled Cross-Over Study.
    Suojanen L; Haring A; Tikkakoski A; Koskela JK; Tahvanainen AM; Huhtala H; Kähönen M; Sipilä K; Eräranta A; Mustonen JT; Kivistö K; Pörsti IH
    Basic Clin Pharmacol Toxicol; 2017 Aug; 121(2):130-137. PubMed ID: 28256104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of heart rate on central aortic pressures and hemodynamics: analysis from the CAFE (Conduit Artery Function Evaluation) study: CAFE-Heart Rate.
    Williams B; Lacy PS;
    J Am Coll Cardiol; 2009 Aug; 54(8):705-13. PubMed ID: 19679248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.